Testing pharmacogenetic indices to predict efficacy and toxicity of methotrexate monotherapy in a rheumatoid arthritis patient cohort

被引：4
|
作者：
Owen, S. A. [1 ]
Lunt, M. [1 ]
Hider, S. L. [2 ]
Bruce, I. N. [1 ]
Barton, A. [1 ]
Thomson, W. [1 ]
机构：
[1] Univ Manchester, Manchester, Lancs, England
[2] Keele Univ, Keele, Staffs, England
来源：
ARTHRITIS AND RHEUMATISM | 2010年 / 62卷 / 12期
关键词：
POLYMORPHISMS; FOLATE; GENE;
D O I：
10.1002/art.27754
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：3827 / 3829
页数：3
相关论文
共 50 条
  • [21] Methotrexate in rheumatoid arthritis: Toxicity issues
    Weinblatt, ME
    [J]. BRITISH JOURNAL OF RHEUMATOLOGY, 1996, 35 (05): : 403 - 405
  • [22] TOXICITY TO METHOTREXATE IN RHEUMATOID-ARTHRITIS
    GISPEN, JG
    ALARCON, GS
    JOHNSON, JJ
    ACTON, RT
    BARGER, BO
    KOOPMAN, WJ
    [J]. JOURNAL OF RHEUMATOLOGY, 1987, 14 (01) : 74 - 79
  • [23] Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? - A Case Report
    Jeiziner, Chiara
    Allemann, Samuel S.
    Hersberger, Kurt E.
    Schwabedissen, Henriette E. Meyer zu
    [J]. PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2022, 15 : 465 - 475
  • [24] Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis
    Fleischmann, Roy M.
    Huizinga, Tom W. J.
    Kavanaugh, Arthur F.
    Wilkinson, Bethanie
    Kwok, Kenneth
    DeMasi, Ryan
    van Vollenhoven, Ronald F.
    [J]. RMD OPEN, 2016, 2 (02):
  • [25] Radiographic healing with sustained clinical remission in a patient with rheumatoid arthritis receiving methotrexate monotherapy
    Wassenberg, S
    Rau, R
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (10): : 2804 - 2807
  • [26] WHICH STRATEGIES IN RHEUMATOID ARTHRITIS PATIENT WITH INADEQUATE RESPONSE TO METHOTREXATE MONOTHERAPY: THE STRATEGE STUDY
    Flipo, R. -M.
    Gaujoux-Viala, C.
    Hudry, C.
    Zinovieva, E.
    Leutenegger, E.
    Herman-Demars, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 109 - 109
  • [27] Methotrexate and Hepatic Toxicity in Rheumatoid Arthritis and Psoriatic Arthritis
    Lindsey Tilling
    Sue Townsend
    Joel David
    [J]. Clinical Drug Investigation, 2006, 26 : 55 - 62
  • [28] Methotrexate and hepatic toxicity in rheumatoid arthritis and psoriatic arthritis
    Tilling, L
    Townsend, S
    David, J
    [J]. CLINICAL DRUG INVESTIGATION, 2006, 26 (02) : 55 - 62
  • [29] Methotrexate: optimizing the efficacy in rheumatoid arthritis
    Braun, Juergen
    [J]. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2011, 3 (03) : 151 - 158
  • [30] Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis
    Hoekstra, M
    van Ede, AE
    Haagsma, CJ
    van de Laar, MAFJ
    Huizinga, TWJ
    Kruijsen, MWM
    Laan, RFJM
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (05) : 423 - 426
12345